Status:
COMPLETED
A Clinical Diagnostic System for Intrinsic Acute Kidney Disease
Lead Sponsor:
Peking University First Hospital
Collaborating Sponsors:
Affiliated Hospital of Hebei University
Beijing Miyun Hospital
Conditions:
Acute Kidney Disease
Eligibility:
All Genders
18-99 years
Brief Summary
The goal of this observational cross-sectional study is to develop a clinical diagnostic system for intrinsic acute kidney disease (AKD) to help clincians make non-invasive diagnosis when a kidney bio...
Detailed Description
Acute kidney disease is a frequent syndrome characterized by a sudden loss of kidney function. AKD caused by intrinsic kidney diseases are usually more severe than other causes. The treatment of intri...
Eligibility Criteria
Inclusion
- Adult patients with AKD undergoing kidney biopsy between Jan. 1, 2020 and Dec. 31, 2024.
Exclusion
- Patients were excluede if they
- underwent a biopsy to evaluate renal allograft rejection;
- had a history of hematopoietic stem cell transplantation;
- were diagnosed with hematological malignancy or end-stage tumor with kidney metastasis;
- were tested antineutrophil cytoplasmic autoantibody (ANCA) or double-strand DNA (dsDNA) or anti-glomerular basement membrane (GBM) antibody positive before biopsy.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2024
Estimated Enrollment :
1360 Patients enrolled
Trial Details
Trial ID
NCT06606522
Start Date
June 1 2024
End Date
September 9 2024
Last Update
September 23 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongzhimen Hospital of Beijing University of Chinese Medicine
Beijing, Beijing Municipality, China, 100007
2
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034
3
Beijing Miyun District Hospital
Beijing, Beijing Municipality, China, 101520
4
Affliated Hospital of Hebei University
Baoding, Hebei, China, 071000